menu search

Advent Therapeutics Awarded $3 Million NIH Grant for Novel Neonatal Lung Therapy

Advent Therapeutics Awarded $3 Million NIH Grant for Novel Neonatal Lung Therapy
Expedites Development of Non-Invasive Inhaled Bronchopulmonary Dysplasia Therapy DOYLESTOWN, Pa., July 18, 2023 (GLOBE NEWSWIRE) — Advent Therapeutics, Inc., a biotechnology company pioneering an optimized retinol palmitate (vitamin A) drug product as a breakthrough non-invasive inhaled neonatal lung therapy, has been awarded a $3 million National Institutes of Health (NIH) Small Business Innovation Research (SBIR) […] The post Advent Therapeutics Awarded $3 Million NIH Grant for Novel Neonatal... Read More
Posted: Jul 18 2023, 11:30
Author Name: forextv
Views: 092112

Search within

Pages Search Results: